Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps

Therapeutic Advances in Respiratory Disease

Volumn 6, Issue 1, 2012, Pages 5-10

  Vuralkan, Erkan ^a   Saka, Cem ^b   Akin, Istemihan ^b   Hucumenoglu, Sema ^b   Unal, Binnur Uzmez ^b   Kuran, Gokhan ^b   Ocal, Berrak ^b  

^a Trabzon Numune Education and Training Hospital   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

glucocorticoids; leukotriene antagonists; mometasone furoate; montelukast; nasal polyposis; recurrence

Indexed keywords

MOMETASONE FUROATE; MONTELUKAST;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; ENDOSCOPIC SURGERY; EOSINOPHIL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT DISEASE;

ACETATES; ADMINISTRATION, INTRANASAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ENDOSCOPY; EOSINOPHILS; ETHMOID SINUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; NASAL POLYPS; NASAL SPRAYS; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; QUINOLINES; RECURRENCE; SPHENOID SINUS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84856596403     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465811427577     Document Type: Article

References (28)

1. Baraniuk J.N. (1997) Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99: 763–772.
2. Bernstein J.M. Garfien J. Noble B. (1995) Role of allergy in nasal polyposis: A review. Otolaryngol Head Neck Surg 113: 724–732.
3. Browne J.P. Hopkins C. Slack R. Cano S.J. (2007) The Sino-Nasal Outcome Test (SNOT): can we make it more clinically meaningful? Otolaryngol Head Neck Surg 136: 736–741.
4. Buckland J.R. Thomas S. Harries P.G. (2003) Can the Sino-nasal Outcome Test (SNOT-22) be used as a reliable outcome measure for successful septal surgery? Clin Otolaryngol Allied Sci 28: 43–47.
5. Dahlén B. Nizankowska E. Szczeklik A. Zetterström O. Bochenek G. Kumlin M. (1998) Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 157: 1187–1194.
6. Davidsson A. Hellquist H.B. (1993) The so-called “allergic” nasal polyp. ORL J Otorhinolaryngol Relat Spec 55: 30–35.
7. Holmberg K. Karlsson G. (1996) Nasal polyps: medical or surgical management? Clin Exp Allergy 26(Suppl. 3): 23–30.
8. Jung T.T. Juhn S.K. Hwang D. Stewart R. (1987) Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 97: 184–189.
9. Karlsson G. Rundcrantz H. (1982) A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 20: 144–148.
10. Keith P.K. Koch C. Djandji M. Bouchard J. Psaradellis E. Sampalis J.S. (2009) Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial). Can Respir J 16(Suppl. A): 17A–31A.
11. Kuran G. Kocaturk S. Kurukahvecioglu S. Erkam U. (2002) The efficacy of combined medical treatment (antihistaminics, steroids, and macrolide antibiotics) in patients with nasal polyposis preliminary results. Kulak Burun Boğaz Ihtisas Derg 9: 352–357.
12. Kutting B. Nieschalk M. Brehler R. (2000) A new concept for treatment of sinonasal polyposis. Allergy 55: 1091–1092.
13. Lamblin C. Brichet A. Perez T. Darras J. Tonnel A.B. Wallaert B. (2000) Long-term follow-up of pulmonary function in patients with nasal polyposis. Am J Respir Crit Care Med 161: 406–413.
14. Lund V.J. Mackay I.S. (1993) Staging in rhinosinusitus. Rhinology 31: 183–184.
15. Lund V.J. Flood J. Sykes A.P. Richards D.H. (1998) Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 124: 513–518.
16. Meco C. Oberascher G. (2004) Comprehensive algorithm for skull base dura lesion and CSF fistula diagnosis. Laryngoscope 114: 991–999.
17. Mullul J. Xaubet A. Lopez E. Roca-Ferrer J. Picado C. (1995) Comparative studies of the effects of different glucocorticoids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 50: 270–274.
18. Parnes S.M. Chuma A.V. (2000) Acute effects of antileukotrienes on sinonasal polyposis and sinusitis. Ear Nose Throat J 79: 18–20, 24-25.
19. Picado C. (2001) Nasal polyposis. Clin Exp Allergy Rev 1: 163–165.
20. Ragab S. Parikh A. Darby Y.C. Scadding G.K. (2001) An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 31(9): 1385–91.
21. Rasp G. Schuck A. Kastenbauer E.R. (2000) A new grading system for nasal polyps of the ethmoid bone. Influence of a combined systemic and local steroid treatment. Laryngorhinootologie 79: 266–273.
22. Stammberger H. Posawetz W. (1990) Functional endoscopic sinus surgery. Concept, indications and results of the Messerklinger technique. Eur Arch Otorhinolaryngol 247: 63–76.
23. Tan R.A. (1998) The role of antileukotriens in asthma management. Curr Opin Pulm Med 4: 25–30.
24. Thomas M. Yawn B.P. Price D. Lund V. (2008) EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007: a summary. Prim Care Respir J 17: 79–89.
25. Tos M. Mogensen C. (1977) Mucous glands in nasal polyps. Arch Otolaryngol 103: 407–413.
26. Tos M. Larsen P.L. Møller K. (1990) Goblet cell density in nasal polyps. Ann Otol Rhinol Laryngol 99: 310–315.
27. Virolainen E. Puhakka H. (1980) The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 18: 9–18.
28. Wardlaw A.J. Hay H. Cromwell O. Collins J.V. Kay A.B. (1989) Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 84: 19–26.